Cell and gene therapy manufacturing operations involve end-to-end complex modular systems, multiple stakeholders, and handoffs with constant data generation. Operational bottlenecks occur when independent systems fail to integrate, preventing visibility into end-to-end manufacturing processes and data.

What We Solve For

We are the first purpose-built orchestration and intelligence platform for cell and gene therapy — connecting every internal and external operation into a single intelligent system, and making it predictive.

Regulatory & Compliance Cellentail auto-generates audit trails and batch records across every operation — so you're always inspection-ready.

Financial Protection One prevented batch failure pays for Cellentail many times over. We reduce the $400K–$500K write-off risk that comes with every CAR-T manufacturing event.

Competitive Differentiation Faster vein-to-vein times. Stronger reimbursement negotiations. Execution quality that becomes a moat.

Payer & Reimbursement We generate the real-world outcomes data your team needs to defend premium pricing and support outcomes-based contracts with confidence.

Supply Chain Resilience Cellentail gives you real-time visibility across every CDMO, logistics partner, and clinical site — so you see disruptions before they become crises.

Our Mission

Every patient who qualifies for a cell or gene therapy should receive it — on time, without a preventable failure anywhere in the chain between the science and the bedside.

That is what Cellentail is built to make possible.